genu
ebolaviru
famili
filovirida
order
mononegaviral
compris
five
recogn
speci
zair
ebolaviru
zebov
repres
prototyp
speci
zebov
signific
human
pathogen
case
fatal
rate
often
reach
date
numer
outbreak
largest
occur
west
africa
result
human
case
high
case
fatal
rate
magnitud
outbreak
west
africa
illustr
press
need
develop
safe
efficaci
vaccin
prevent
futur
zebov
outbreak
zebov
particl
filament
zebov
genom
consist
nonseg
negativesens
singlestrand
rna
molecul
approxim
encod
eight
protein
nucleoprotein
np
virion
protein
vp
glycoprotein
gp
secret
glycoprotein
sgp
rnadepend
rna
polymeras
l
notabl
gp
mediat
attach
fusion
virion
affect
previou
studi
shown
immun
gp
effect
mean
elicit
protect
immun
respons
lethal
zebov
challeng
due
gp
contain
import
neutral
function
vesicular
stomat
viru
vsv
order
mononegaviral
famili
rhabdovirida
genu
vesiculoviru
envelop
viru
contain
nonseg
singlestrand
negativesens
rna
genom
approxim
genom
encod
five
viral
protein
nucleoprotein
n
phosphoprotein
p
matrix
glycoprotein
g
larg
protein
l
epidemiolog
ecolog
naturallycircul
vesiculovirus
remain
poorli
understood
vs
virus
andor
serolog
evid
exposur
vsv
found
divers
domest
wild
vertebr
two
serotyp
vsv
vsvindiana
vsvnew
jersey
transmit
mammal
hematophag
insect
well
direct
contact
via
transcutan
transmucos
transmiss
compet
insect
vector
vsv
includ
bite
midg
culicoid
spp
phlebotomin
sand
fli
lutzomyia
phlebotomu
spp
black
fli
simulium
spp
clinic
ill
cattl
hors
pig
result
vsv
infect
includ
vesicul
ulcer
eros
oral
nasal
mucosa
epitheli
surfac
tongu
coronari
band
preval
clinic
case
cattl
herd
gener
low
seropreval
within
herd
may
approach
vsv
proven
success
vector
develop
sever
liveattenu
vaccin
candid
due
abil
accept
stabli
express
foreign
gene
product
heterolog
develop
safe
efficaci
singledos
vaccin
zebov
g
gene
vsv
replac
immunogen
glycoprotein
gp
gene
zebov
result
vsv
virion
particl
express
zebov
gp
surfac
result
construct
also
refer
replic
compet
liveattenu
vaccin
attenu
replic
narrow
hostcel
tropism
vitro
wildtyp
result
construct
test
sever
anim
model
includ
mice
nonhuman
primat
nhp
shown
safe
elicit
robust
protect
immun
vaccin
test
sever
clinic
trial
shown
accept
safeti
profil
immunogen
highli
effect
prevent
ebola
viru
diseas
evd
induc
zebov
viremia
detect
gener
first
day
vaccin
low
level
discuss
howev
due
vectorborn
potenti
wildtyp
vsv
certain
environment
concern
must
address
develop
live
attenu
vaccin
use
arboviru
vaccin
vector
introduc
risk
immun
person
might
develop
viremia
high
enough
suscept
insect
becom
infect
potenti
transmit
vaccin
phenomenon
document
venezuelan
equin
enceph
viru
vaccin
isol
mosquito
louisiana
follow
use
hors
stop
epidem
case
backbon
arboviru
prior
experiment
evid
demonstr
ebola
reston
viru
incap
replic
therefor
hypothes
vaccin
would
replic
arthropod
cell
live
mosquito
furthermor
addit
inclus
wildtyp
vsvindiana
strain
vsvi
control
throughout
studi
includ
anoth
vsv
construct
g
gene
vsv
replac
structur
cassett
san
capsid
semliki
forest
viru
sfv
term
rvsvsfv
control
rational
includ
rvsvsfv
hypothes
would
replic
arthropod
due
natur
transmiss
sfv
mosquito
demonstr
inabl
replic
arthropod
vitro
vivo
due
replac
arboviru
envelop
cassett
zebov
gp
gene
experi
conduct
determin
whether
replic
arthropod
cell
evalu
replic
kinet
three
virus
sever
relev
insect
vector
cell
line
deriv
mosquito
genera
aed
anophel
bite
midg
genu
culicoid
sand
fli
genu
lutzomyia
also
assess
replic
potenti
live
aed
culex
mosquito
expos
via
infecti
blood
meal
intrathorac
inocul
studi
confirm
inabl
replic
arthropod
vitro
vivo
interestingli
also
found
rvsvsfv
also
unabl
replic
arthropod
vitro
vivo
viru
replic
assess
multipl
arthropod
cell
line
figur
repres
taxa
serv
actual
potenti
vector
vsv
field
growth
curv
conduct
triplic
multipl
infect
moi
back
titrat
conduct
inoculum
confirm
within
twofold
desir
inoculum
titer
viru
replic
high
titer
vero
cell
caus
signific
cytopath
effect
cpe
confirm
util
cell
line
viru
quantif
purpos
figur
anophelin
aed
bite
midg
cuva
sand
fli
cell
line
replic
observ
vsvi
either
rvsvsfv
figur
cell
line
viru
titer
vsvi
significantli
higher
pvalu
rvsvsfv
determin
twoway
anova
tukey
correct
timepoint
figur
assess
abil
replic
mosquito
culex
quinquefasciatu
cx
quinquefasciatu
aed
aegypti
ae
aegypti
inocul
vsvi
rvsvsfv
stock
titer
vsvi
pfuml
rvsvsfv
stock
titer
pfuml
mosquito
inocul
nl
stock
viru
approxim
pfu
vsvi
pfu
rvsvsfv
due
small
volum
viru
inocul
mani
dose
fell
limit
detect
lod
assay
viru
replic
appar
later
timepoint
tabl
follow
inocul
mosquito
harvest
day
infecti
viru
quantifi
plaqu
assay
vero
cell
overal
vsvi
replic
mosquito
speci
reach
peak
titer
approxim
pfu
per
mosquito
two
eight
day
post
inocul
dpi
follow
inocul
cx
quinquefasciatu
mosquito
recov
one
three
mosquito
eight
day
post
inocul
furthermor
recov
one
three
ae
aegypti
mosquito
day
post
inocul
addit
rvsvsfv
recov
one
three
mosquito
dpi
ae
aegypti
mosquito
rvsvsfv
recov
cx
quinquefasciatu
day
post
inocul
rvsvsfv
detect
found
individu
mosquito
late
timepoint
exceed
dose
inocul
result
believ
repres
detect
vaccin
persist
mosquito
follow
inocul
rather
result
activ
replic
viru
comparison
vsvi
found
inocul
mosquito
day
post
inocul
replic
mean
titer
approxim
pfu
approxim
higher
inoculum
dose
day
postinocul
viru
titer
detect
mosquito
significantli
differ
measur
kruskalw
test
dunn
multipl
comparison
posttest
cx
quinquefasciatu
mosquito
vsvi
significantli
differ
pvalu
rvsvsfv
pvalu
respect
vsvi
also
significantli
differ
ae
aegypti
mosquito
compar
rvsvsfv
pvalu
respect
determin
capabl
infect
dissemin
mosquito
midgut
follow
oral
exposur
assess
presenc
low
level
rvsvsfv
persist
inocul
mosquito
cx
quinquefasciatu
ae
aegypti
mosquito
expos
infecti
blood
meal
contain
either
vsvi
rvsvsfv
day
post
exposur
bodi
measur
midgut
infect
leg
wing
measur
dissemin
collect
assess
presenc
infecti
viru
blood
meal
titer
confirm
backtitr
cx
quinquefasciatu
mosquito
backtit
pfuml
vsvi
pfuml
pfuml
rvsvsfv
ae
aegypti
mosquito
backtit
pfuml
vsvi
pfuml
pfuml
rvsvsfv
day
post
exposur
cx
quinquefasciatu
mosquito
becam
infect
vsvi
tabl
mosquito
develop
dissemin
infect
data
indic
presenc
signific
midgut
infect
barrier
cx
quinquefasciatu
expos
vsvi
ae
aegypti
mosquito
becam
infect
vsvi
develop
dissemin
infect
tabl
data
demonstr
ae
aegypti
mosquito
suscept
infect
vsvi
cx
quinquefasciatu
moder
midgut
infect
barrier
still
present
speci
ae
aegypti
cx
quinquefasciatu
mosquito
becam
infect
either
rvsvsfv
titer
recov
viru
mosquito
record
tabl
viru
stabil
experi
conduct
use
mosquito
homogen
spike
viru
incub
day
followup
detect
rvsvsfv
live
mosquito
later
experiment
time
point
day
follow
inocul
tabl
sinc
titer
viru
detect
mosquito
exceed
titer
origin
inoculum
hypothes
viru
detect
due
persist
stabl
replicationcompet
viru
origin
inoculum
rather
result
activ
replic
mosquito
tissu
experi
reveal
titer
virus
declin
time
replicationcompet
viru
particl
present
mosquito
homogen
day
cx
quinquefasciatu
day
ae
aegypti
figur
twoway
anova
conduct
tukey
multipl
comparison
test
compar
mean
titer
viru
group
compar
viru
stabil
vsvi
viru
titer
significantli
differ
aed
culex
mosquito
suspens
similar
pattern
observ
compar
viru
stabil
vsvi
rvsvsfv
result
consist
result
inocul
support
hypothesi
low
level
thermost
viru
may
persist
highli
unlik
replic
mosquito
follow
inocul
studi
demonstr
ebola
viru
vaccin
replic
arthropod
cell
line
examin
live
culex
aed
mosquito
follow
intrathorac
inocul
oral
exposur
wildtyp
vsvi
recogn
potenti
transmit
divers
taxa
arthropod
vector
includ
mosquito
sand
fli
bite
activ
replic
vsvi
itinocul
ae
aegypti
mosquito
previous
henc
cell
line
mosquito
genera
use
studi
select
base
previou
field
isol
demonstr
laboratori
insect
group
replic
transmiss
vsv
expect
vsvi
replic
cell
line
examin
well
genera
mosquito
demonstr
relev
arthropod
group
includ
studi
import
evalu
replic
potenti
vaccin
divers
insect
taxa
expect
substitut
glycoprotein
nonvectorborn
viru
zebov
ablat
abil
vsv
infect
replic
variou
arthropod
cell
line
well
live
mosquito
three
virus
replicationcompet
vero
cell
howev
vsvi
grew
ae
albopictu
gambia
cuva
c
sonorensi
l
longipalpi
cell
live
culex
aed
mosquito
overal
result
support
work
turel
et
al
found
replic
ebola
reston
viru
viru
inocul
mosquito
expect
would
replic
arthropod
cell
inabl
rvsvsfv
replic
arthropod
cell
unexpect
purpos
includ
rvsvsfv
show
glycoprotein
vsv
replac
anoth
arboviru
case
sfv
result
recombin
vsv
would
capabl
replic
arthropod
cell
result
confirm
main
hypothesi
incap
replic
arthropod
cell
result
obtain
rvsvsfv
demonstr
need
research
mechan
determin
host
rang
vsv
chimer
virus
inde
system
could
lead
mani
insight
regard
infect
arthropod
cell
rvsvsfv
construct
vsv
g
gene
replac
full
structur
cassett
sfv
san
capsid
given
abil
rvsvsfv
replic
cell
deriv
vertebr
host
deriv
arthropod
construct
could
use
determin
key
mediat
host
rang
infect
alphavirus
arbovirus
gener
specif
step
viral
replic
prevent
format
progeni
virion
arthropod
cell
expos
rvsvsfv
current
unknown
howev
like
block
occur
point
attach
entri
viru
mechan
associ
viru
attach
entri
arthropod
long
remain
cryptic
alphavirus
tool
could
lead
import
insight
regard
mechan
intrins
viru
arthropod
allow
infect
progress
experi
reveal
replic
kinet
vsvi
cell
atyp
compar
arthropod
cell
line
figur
given
differenti
suscept
mosquito
cell
type
infect
vsv
cell
compris
cell
line
deriv
larval
ae
albopictu
perhap
permiss
infect
vsv
compar
cell
type
avail
virus
infect
live
mosquito
bergold
et
al
studi
tissu
tropism
vsvi
vsvnew
jersey
strain
ae
aegypti
follow
intrathorac
inocul
demonstr
vsv
infect
divers
mosquito
tissu
cours
infect
viru
concentr
per
microgram
tissu
highest
thorac
abdomin
ganglia
day
post
inocul
salivari
gland
day
post
clone
deriv
origin
saar
ae
albopictu
cell
line
select
increas
permiss
replic
dengu
chikungunya
howev
select
may
favor
replic
virus
other
specif
reason
cell
line
support
replic
vsvi
extent
arthropod
cell
line
despit
replic
viru
closelyrel
live
mosquito
vector
speci
deserv
studi
vaccin
inocul
cx
quinquefasciatu
ae
aegypti
mosquito
demonstr
presenc
replicationcompet
viru
small
proport
intrathoracicallyinocul
mosquito
low
titer
follow
inocul
tabl
result
followup
experi
investig
viru
stabil
homogen
mosquito
matrix
consist
data
itinocul
support
hypothesi
lowlevel
persist
mosquito
due
biolog
stabil
viru
rather
activ
replic
figur
persist
replicationcompet
viru
particl
vsvi
present
homogen
mosquito
matrix
day
cx
quinquefasciatu
homogen
day
ae
aegypti
homogen
figur
addit
rvsvsfv
detect
intermitt
day
ae
aegypti
result
consist
result
intrathorac
inocul
wherebi
persist
detect
inocul
cx
quinquefasciatu
day
postinocul
ae
aegypti
day
post
inocul
tabl
viru
persist
ae
aegypti
longer
cx
quinquefasciatu
biolog
stabil
test
intrathorac
inocul
unclear
mosquito
homogen
differ
environ
viru
compar
live
mosquito
tissu
data
provid
evid
replicationcompet
viru
particl
vaccin
abl
persist
disrupt
environ
one
two
week
figur
therefor
vaccin
detect
mosquito
follow
inocul
like
repres
residu
inoculum
result
activ
replic
mosquito
tissu
conclus
also
support
failur
replic
vitro
mosquito
cell
develop
posit
strandspecif
rtpcr
would
one
approach
specif
test
presenc
activelyrepl
viru
sampl
itinocul
importantli
demonstr
fail
infect
mosquito
follow
oral
exposur
infect
blood
meal
contain
high
concentr
viru
experi
evalu
way
mosquito
could
becom
infect
natur
condit
bloodfeed
vaccin
human
wildtyp
vsvi
shown
infect
ae
aegypti
cx
quinquefasciatu
mosquito
although
midgut
infect
barrier
present
speci
tabl
result
consist
studi
found
moder
level
viru
dissemin
ae
aegypti
mosquito
fed
virem
mice
infect
infecti
blood
meal
titer
experi
maxim
ensur
probabl
mosquito
becom
infect
high
possibl
case
mosquito
expos
pfuml
viru
becom
infect
importantli
human
vaccin
develop
transient
viremia
peak
approxim
probabl
mosquito
becom
infect
feed
infecti
blood
meal
significantli
declin
titer
pfuml
due
small
size
mosquito
blood
meal
likelihood
imbib
viru
particl
low
circul
therefor
data
quantit
viremia
data
clinic
studi
indic
extrem
low
probabl
mosquito
becom
infect
feed
vaccin
individu
consid
vaccin
lack
surfac
glycoprotein
arboviru
replic
mosquito
bite
midg
sand
fli
cell
infect
relev
mosquito
vector
speci
result
support
extrem
low
risk
arthropodborn
transmiss
vaccin
vero
african
green
monkey
kidney
cell
atcc
maintain
dulbecco
minim
essenti
media
dmem
supplement
fetal
bovin
serum
fb
nonessenti
amino
acid
sodium
pyruv
penicillinstreptomycin
ps
gentamycin
amphotericin
b
cell
store
humidifi
incub
aed
albopictu
cell
atcc
maintain
dmem
supplement
fb
ps
anophel
gambia
maintain
schneider
media
supplement
fb
ps
sand
fli
lutzomyia
longipalpi
maintain
schneider
media
supplement
fb
ps
media
cuva
bite
midg
culicoid
sonorensi
formerli
c
varipenni
formul
ad
g
powder
schneider
media
sigmaaldrich
st
loui
mo
water
stir
continu
follow
ad
media
g
sodium
bicarbon
mg
lglutamin
mg
reduc
glutathion
mg
lasparagin
bovin
insulin
umg
ph
brought
via
addit
g
naoh
pellet
stir
minut
stir
ph
brought
via
addit
ml
hcl
g
cacl
dissolv
ml
water
ad
media
via
transfer
pipett
prevent
format
precipit
water
ad
bring
total
volum
l
media
filter
filter
prior
supplement
fb
arthropod
cell
store
humidifi
incub
passag
rang
cell
cultur
use
experi
follow
vero
passag
cuva
cell
cultur
test
neg
mycoplasma
mosquito
speci
use
studi
ae
aegypti
strain
poza
rica
cx
quinquefasciatu
poza
rica
strain
ae
aegypti
year
establish
origin
sourc
fieldcollect
materi
poza
rica
mexico
approxim
gener
cx
quinquefasciatu
coloni
origin
collect
sebr
counti
florida
continu
maintain
aidl
mosquito
rear
condit
infecti
diseas
research
center
idrc
discoveri
suit
csu
foothil
campu
light
dark
cycl
rel
humid
approxim
day
emerg
adult
femal
mosquito
transport
idrc
phase
iii
virolog
suit
experiment
infect
vaccin
lot
number
clinic
trial
materi
made
accord
good
manufactur
practic
use
studi
fresh
vial
viru
thaw
everi
experi
prior
experiment
viru
titer
lot
confirm
pfuml
titrat
one
vial
vero
cell
plaqu
assay
triplic
previous
rvsvsfv
provid
sean
whelan
harvard
univers
rvsvsfv
vsvi
viru
g
protein
replac
structur
cassett
sfv
san
capsid
addit
stock
gener
vero
cell
via
infect
moi
infecti
media
harvest
hour
post
infect
hpi
clarifi
via
centrifug
minut
fb
concentr
brought
store
viru
titer
determin
via
vero
cell
plaqu
assay
prior
experiment
previous
wildtyp
vsvi
strain
isol
hors
outbreak
colorado
obtain
intern
colorado
state
univers
csu
use
posit
control
studi
inform
avail
regard
passag
histori
viru
case
histori
anim
isol
viru
verifi
indiana
strain
csu
veterinari
diagnost
laboratori
quantit
revers
transcriptas
polymeras
chain
reaction
qrtpcr
ct
addit
stock
gener
describ
viru
titer
determin
via
vero
cell
plaqu
assay
prior
experiment
previous
growth
kinet
virus
assess
cell
cultur
flask
vero
cuva
cell
inocul
triplic
viru
mock
infect
control
moi
addit
mock
flask
cell
line
use
count
cell
prior
inocul
accur
moi
calcul
inoculum
allow
adsorb
one
hour
appropri
temperatur
vero
cell
insect
cell
follow
incub
viru
inoculum
remov
vero
cell
wash
time
phosphat
buffer
salin
pb
insect
cell
wash
time
appropri
cell
cultur
media
mainten
media
ad
hour
postinfect
supernat
harvest
brought
fb
frozen
later
plaqu
titrat
back
titrat
conduct
aliquot
inoculum
confirm
within
desir
titer
viral
titer
supernat
sampl
determin
vero
cell
plaqu
test
viru
replic
vivo
group
least
cx
quinquefasciatu
ae
aegypti
mosquito
inocul
nl
stock
viru
suspens
use
drummond
scientif
nanoject
ii
autonanolit
injector
exact
inoculum
dose
provid
result
inocul
approxim
day
old
femal
mosquito
use
exact
age
mosquito
known
pupat
emerg
slightli
asynchron
mosquito
hous
screen
paperboard
pint
contain
held
rel
humid
light
dark
cycl
mosquito
provid
sugar
water
ad
libitum
three
five
mosquito
harvest
immedi
inocul
titrat
viru
inoculum
day
post
inocul
mosquito
homogen
ml
eppendorf
safelock
tube
steal
bead
mosquito
diluent
pb
supplement
fb
ps
gentamycin
amphotericin
b
via
tritur
one
minut
retsch
mixer
mill
debri
mosquito
centrifug
minut
clarifi
supernat
use
determin
viru
titer
vero
cell
previous
assess
viru
infect
dissemin
mosquito
speci
follow
oral
exposur
infecti
blood
meal
group
ae
aegypti
cx
quinquefasciatu
mosquito
expos
vsvi
rvsvsfv
approxim
dayold
mosquito
administ
blood
meal
contain
defibrin
sheep
blood
mm
adenosin
triphosph
atp
thaw
viru
stock
viru
stock
dilut
prior
blood
meal
prepar
maxim
viru
concentr
mosquito
expos
infecti
blood
meal
provid
via
water
heat
glass
membran
feeder
use
hog
gut
membran
follow
onehour
feed
mosquito
anesthet
fullyengorg
femal
separ
new
carton
maintain
sucros
water
day
backtitr
infecti
blood
meal
perform
vero
cell
confirm
viru
titer
infecti
blood
meal
titer
provid
result
day
post
exposur
allow
plenti
time
dissemin
occur
mosquito
group
anesthet
cold
treatment
leg
wing
remov
transfer
ml
eppendorf
safelock
tube
contain
mosquito
diluent
stainless
steel
bead
homogen
bodi
place
separ
ml
eppendorf
safelock
tube
prepar
similarli
mosquito
tissu
prep
titrat
describ
address
question
regard
vaccin
stabil
inocul
mosquito
experi
design
wherebi
suspens
homogen
culex
aed
mosquito
spike
approxim
pfu
wt
vsvi
pfu
rvsvsfv
incub
triplic
mosquito
suspens
contain
five
mosquito
homogen
mosquito
diluent
ten
microlit
gentamycin
amphotericin
b
ad
sampl
everi
day
prevent
bacteri
fungal
growth
aris
mosquito
homogen
aliquot
spike
homogen
titrat
hour
post
infect
vero
cell
plaqu
usda
anim
plant
health
inspect
servic
aphi
permit
issu
dr
rebekah
kade
permit
receipt
domest
strain
vsv
research
project
approv
csu
institut
biosafeti
committe
protocol
